Condensed Consolidated Statements Of Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Common Stock	Retained Earnings	Accumulated Other Comprehensive Loss	Total
Balance, beginning of period at Dec. 31, 2022	$ 1,298,740	$ 323,288	$ (105,319)	$ 1,516,709
Balance, beginning of period (in shares) at Dec. 31, 2022	151,935
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(5,165)		(5,165)
Foreign currency translation adjustments			8,432	8,432
Repurchases of common stock	$ (5,006)			(5,006)
Repurchases of common stock (in shares)	(660)
Activity in company stock plans, net and other	$ (742)			(742)
Activity in company stock plans, net and other (in shares)	219
Share-based compensation	$ 1,492			1,492
Balance, end of period at Mar. 31, 2023	$ 1,294,484	318,123	(96,887)	1,515,720
Balance, end of period (in shares) at Mar. 31, 2023	151,494
Balance, beginning of period at Dec. 31, 2023	$ 1,271,565	312,450	(83,015)	1,501,000
Balance, beginning of period (in shares) at Dec. 31, 2023	152,291
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(26,287)		(26,287)
Foreign currency translation adjustments			(6,683)	(6,683)
Settlement of convertible debt conversion	$ (84)			(84)
Repurchases of common stock	$ (5,032)			(5,032)
Repurchases of common stock (in shares)	(463)
Termination of capped calls	$ 4,381			4,381
Activity in company stock plans, net and other	$ (2,071)			(2,071)
Activity in company stock plans, net and other (in shares)	622
Share-based compensation	$ 1,598			1,598
Balance, end of period at Mar. 31, 2024	$ 1,270,357	$ 286,163	$ (89,698)	$ 1,466,822
Balance, end of period (in shares) at Mar. 31, 2024	152,450